rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

HCL Technologies Ltd.

532281 HCLTECH Group (A)

27 Sep,15:28
1809.85
24.55 (1.38%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

HCL Technologies Ltd.

BUYSELL

162,981 1,785.30 1,827.85 - 1,795.05 1,828.60 - 1,210.00 491,139.00
NSE | BSE

HCL Technologies Ltd.

HCLTECH

27 Sep,15:57
1808.40
24.55 (1.38%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

HCL Technologies Ltd.

BUYSELL

4,099,015 1783.85 1,828.55 - 1,796.55 1,828.00 - 1,208.55 7,421,758,539.30
(Rs. Crore)

Financial Results of HCL Technologies Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales48,118.0046,276.0040,638.0035,673.0032,606.00
Operating profit16,876.0016,243.0015,112.0014,435.0012,780.00
Interest125.00127.00109.00177.00238.00
Gross profit17,827.0017,147.0015,883.0015,223.0013,129.00
EPS (Rs)43.0042.2140.0532.2033.03

See more in Research Center »

About HCL Technologies Ltd.

HCL Technologies Limited (d/b/a HCLTech), is an Indian multinational information technology (IT) consulting company headquartered in Noida. Founded by Shiv Nadar, it was spun out in 1991 when HCL entered into the software services business. The company has offices in 60 countries and over 220,000 employees. Wikipedia

News for Information Technology

DPIIT to...
DPIIT to Decriminalise Minor Offences with Jan Vishwas 2.0
DPIIT is working on 100 rules to decriminalise minor offenses under Jan Vishwas 2.0, aimed at promoting ease of doing business and reducing bureaucratic hurdles.
Sep 28, 2024 18:51
Meesho Festive...
Meesho Festive Sale: 6.5 Cr Visitors, Orders Double
Meesho's 'Mega Blockbuster Sale' sees a record-breaking 6.5 crore unique visitors on Day 1, with orders doubling compared to last year. Mamaearth, Denver, Swiss Beauty, and other brands see...
Sep 28, 2024 18:11
Emerald Haven...
Emerald Haven Realty Acquires Land in Bengaluru, Chennai
Emerald Haven Realty has acquired two land parcels in North Bengaluru and Chennai, offering a combined revenue of Rs 900 crore. The company plans to develop premium residential projects in these...
Sep 28, 2024 18:04
Zydus Gets USFDA...
Zydus Gets USFDA Approval for Generic Prostate Cancer Drug
Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide capsules (40 mg), a generic prostate cancer treatment drug. The drug will be produced at the company's Moraiya, Ahmedabad...
Sep 28, 2024 17:49
Biocon Gets USFDA...
Biocon Gets USFDA Observations for Bengaluru API Facility
Biocon's Bengaluru-based API facility received four observations from the USFDA following an inspection. The company plans to address the observations within the stipulated time.
Sep 28, 2024 17:49

More News »

Top News

India SME Forum Launches 'Start Exporting in Eight Weeks' Program
India SME Forum launches 'Start Exporting in Eight Weeks' program to help MSMEs access global markets and boost exports. The initiative, in partnership with Amazon, aims to equip MSMEs with...
Sep 28, 2024 19:07
DPIIT to...
DPIIT to Decriminalise Minor Offences with Jan Vishwas 2.0
DPIIT is working on 100 rules to decriminalise minor offenses under Jan Vishwas 2.0, aimed at promoting ease of doing business and reducing bureaucratic hurdles.
Sep 28, 2024 18:51
Meesho Festive...
Meesho Festive Sale: 6.5 Cr Visitors, Orders Double
Meesho's 'Mega Blockbuster Sale' sees a record-breaking 6.5 crore unique visitors on Day 1, with orders doubling compared to last year. Mamaearth, Denver, Swiss Beauty, and other brands see...
Sep 28, 2024 18:11
Emerald Haven...
Emerald Haven Realty Acquires Land in Bengaluru, Chennai
Emerald Haven Realty has acquired two land parcels in North Bengaluru and Chennai, offering a combined revenue of Rs 900 crore. The company plans to develop premium residential projects in these...
Sep 28, 2024 18:04
Zydus Gets USFDA...
Zydus Gets USFDA Approval for Generic Prostate Cancer Drug
Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide capsules (40 mg), a generic prostate cancer treatment drug. The drug will be produced at the company's Moraiya, Ahmedabad...
Sep 28, 2024 17:49

More Top News »

Report Card

PE Ratios
42.08
EPS (Rs.)
43.00
Sales (Rs. Cr)
11,784.00
Face Value (Rs.)
2
Net Profit Margin (%)
24.26
Last Bonus
1:1
Last Dividend(%)
Return on Average Equity
29.57

Compare 'HCL Technologies Ltd.' with other stocks

  • Tata Consultancy Services Ltd.
  • 4,291.25
  • Compare
  • Oracle Financial Services Software Ltd.
  • 11,284.90
  • Compare
  • Persistent Systems Ltd.
  • 5,426.40
  • Compare

Most Active

  • Change (Rs.)
  •  

HCL Technologies Ltd. performance snapshot

If you had invested Rs.  in HCL Technologies Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add HCL Technologies Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add HCL Technologies Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close